These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35116507)

  • 1. Diagnostic accuracy of circulating miR-126 for malignant pleural mesothelioma: a systematic review and meta-analysis.
    Zhang L; Zhou Q; Han YQ; Li P; Ouyang PH; Wang MY; Hu ZD
    Transl Cancer Res; 2021 Apr; 10(4):1856-1862. PubMed ID: 35116507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis.
    Ren R; Yin P; Zhang Y; Zhou J; Zhou Y; Xu R; Lin H; Huang C
    Oncotarget; 2016 Dec; 7(51):84851-84859. PubMed ID: 27769044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: a systematic review and meta-analysis.
    Hu ZD; Liu XF; Liu XC; Ding CM; Hu CJ
    Clin Chim Acta; 2014 Jun; 433():44-8. PubMed ID: 24607327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
    Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum diagnostic markers for malignant pleural mesothelioma: a narrative review.
    Wang JJ; Yan L
    Transl Cancer Res; 2022 Dec; 11(12):4434-4440. PubMed ID: 36644178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.
    Muraoka T; Soh J; Toyooka S; Aoe K; Fujimoto N; Hashida S; Maki Y; Tanaka N; Shien K; Furukawa M; Yamamoto H; Asano H; Tsukuda K; Kishimoto T; Otsuki T; Miyoshi S
    Lung Cancer; 2013 Dec; 82(3):485-90. PubMed ID: 24168922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis.
    Cui A; Jin XG; Zhai K; Tong ZH; Shi HZ
    BMJ Open; 2014 Feb; 4(2):e004145. PubMed ID: 24566531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on systematic reviews of diagnostic test accuracy.
    Zan X; Wang Y; Shi J; Zhao L; Zhao Y; Liu R; Zhou Y; Wan Y;
    Medicine (Baltimore); 2019 Jun; 98(24):e16028. PubMed ID: 31192957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis.
    Lin H; Shen YC; Long HY; Wang H; Luo ZY; Wei ZX; Hu SQ; Wen FQ
    Int J Clin Exp Med; 2014; 7(5):1289-96. PubMed ID: 24995085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of cancer ratio for malignant pleural effusion: a systematic review and meta-analysis.
    Han YQ; Zhang L; Yan L; Ouyang PH; Li P; Hu ZD
    Ann Transl Med; 2019 Oct; 7(20):554. PubMed ID: 31807535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma.
    Lu Z; Zhang W; Huang K; Zhu M; Gu X; Wei D; Shi M; Chen Y; Wang H
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of combination of biomarkers for malignant pleural mesothelioma: a systematic review and meta-analysis.
    Zhu M; Lu Z; Guo H; Gu X; Wei D; Zhang Z
    Front Oncol; 2023; 13():1136049. PubMed ID: 37114132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma.
    Andersen M; Grauslund M; Ravn J; Sørensen JB; Andersen CB; Santoni-Rugiu E
    J Mol Diagn; 2014 Jul; 16(4):418-30. PubMed ID: 24912849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions.
    Birnie KA; Prêle CM; Musk AWB; de Klerk N; Lee YCG; Fitzgerald D; Allcock RJN; Thompson PJ; Creaney J; Badrian B; Mutsaers SE
    Dis Markers; 2019; 2019():8628612. PubMed ID: 31481984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
    Cheng YY; Wright CM; Kirschner MB; Williams M; Sarun KH; Sytnyk V; Leshchynska I; Edelman JJ; Vallely MP; McCaughan BC; Klebe S; van Zandwijk N; Lin RC; Reid G
    Mol Cancer; 2016 Jun; 15(1):44. PubMed ID: 27245839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.
    Matboli M; Shafei AE; Azazy AE; Reda M; El-Khazragy N; Nagy AA; Ali MA; Sobhi M; Abdel-Rahman O
    Biomark Med; 2018 Feb; 12(2):129-139. PubMed ID: 29338319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1 induces growth arrest and apoptosis in malignant mesothelioma.
    Xu Y; Zheng M; Merritt RE; Shrager JB; Wakelee HA; Kratzke RA; Hoang CD
    Chest; 2013 Nov; 144(5):1632-1643. PubMed ID: 23828229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
    Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
    Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
    PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.